Clinical trial
A Phase III Study Comparing Concurrent Nitroglycerin With Radiation Therapy vs Radiation Therapy Alone in Patients With Non-small Cell Lung Cancer With EGFR Mutations and Brain Metastases.
NCT06238882 is registered in ClinicalTrials.gov with Instituto Nacional de Cancerologia de Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Study Comparing Concurrent Nitroglycerin With Radiation Therapy vs Radiation Therapy Alone in Patients With Non-small Cell Lung Cancer With EGFR Mutations and Brain Metastases.
- Lead sponsor
- Instituto Nacional de Cancerologia de Mexico
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 23, 2023
- Completion date
- February 15, 2027
- Enrollment
- 74 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain metastases, egfr gene mutation, non-small cell lung cancer